Ultra-high Dose Radiation for Liver Metastasis Using MR-guided TReatment With Stereotactic Ablative Single-fraction
Clinical trial NCT06362395 · RECRUITING
Trial details
- NCT number
- NCT06362395
- Sponsor
- University Health Network, Toronto
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-05
- Primary completion
- 2031-09-01
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.